The Ministry of Health and Prevention (MoHAP) has partnered with the World Bank Group to conduct a comprehensive study titled “The Cost of the Most Common Diseases in the UAE". The study is aimed at shaping healthcare policies by utilizing detailed data to better allocate financial resources, ultimately improving healthcare services and enhancing the quality of life for future generations.
The study will focus on assessing the economic impact and calculating the costs associated with the most prevalent diseases in the UAE. This will provide updated information essential for prioritizing healthcare financing, allowing resources to be directed toward the most effective and impactful programs. The initiative also seeks to optimize health resource management and formulate strategies that align with future healthcare trends at both local and global levels.
The agreement was signed by HE Dr. Amin Hussein Al Amiri, Assistant Undersecretary for the Health Regulation Sector at MoHAP, and Safaa El Tayeb El Kogali, the World Bank's Country Director for GCC countries. The signing ceremony was attended by a number of officials, experts, and specialists from both the public and private sectors.